CBIO Catalyst Biosciences, Inc. gains 195% Jan 16, 2018

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-195-percent-a-Trade-Record-by-priceSeries-2017111520180116.html

Blog Archive

► 2022 (84)
- ► March (7)
- ► February (16)
- ► January (61)

► 2021 (1152)
- ► December (10)
- ► November (85)
- ► October (100)
- ► September (64)
- ► August (28)
- ► July (20)
- ► June (142)
- ► May (66)
- ► April (35)
- ► March (280)
- ► February (161)
- ► January (161)

► 2020 (1492)
- ► December (383)
- ► November (31)
- ► October (61)
- ► September (56)
- ► August (201)
- ► July (76)
- ► June (181)
- ► May (191)
- ► April (90)
- ► March (25)
- ► February (51)
- ► January (146)

► 2019 (689)
- ► December (113)
- ► November (81)
- ► October (25)
- ► September (58)
- ► August (44)
- ► July (48)
- ► June (31)
- ► May (45)
- ► April (34)
- ► March (204)
- ► February (6)

▼ 2018 (1350)
- ► October (16)
- ► September (153)
- ► August (82)
- ► July (89)
- ► June (263)
- ► May (156)
- ► April (67)
- ► March (160)
- ► February (95)
- ▼ January (269)

► 2017 (1001)
- ► December (104)
- ► November (113)
- ► October (292)
- ► September (127)
- ► August (87)
- ► July (115)
- ► June (113)
- ► May (50)

► 2015 (96)
- ► July (96)